Zhengye Biotechnology Holding (ZYBT) Equity Ratio (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Equity Ratio data on file, last reported at 0.7 in Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.7, down 1.68% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.7 (down 1.68% YoY), and the FY2025 annual result was 0.7, up 22.06% from the prior year.
• Equity Ratio declined to 0.7 in Q4 2025 per ZYBT's latest filing, from 0.72 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.72 in Q2 2025 and troughed at 0.68 in Q4 2023.
• A 3-year average of 0.7 and a median of 0.71 in 2024 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2024 and 2025: Equity Ratio gained 5.31% in 2024, then decreased 1.68% in 2025.
• A 3-year view of Equity Ratio shows it stood at 0.68 in 2023, then climbed by 5.31% to 0.71 in 2024, then slipped by 1.68% to 0.7 in 2025.
• Business Quant data shows ZYBT's Equity Ratio at 0.7 in Q4 2025, 0.72 in Q2 2025, and 0.71 in Q4 2024.